STOCK TITAN

Avanos Medical, Inc. Launches PainBlock Pro App

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Avanos Medical, Inc. (NYSE: AVNS) has launched the PainBlock Pro app, designed for real-time patient recovery tracking post-surgery. The app collects patient-reported outcomes (PROs) via daily surveys for up to 10 days, helping providers tailor pain management plans based on pain levels and opioid use. It also offers patients easy access to FAQs and educational resources. Bill Haydon, Senior VP at Avanos, emphasized the app's role in enhancing patient-provider interaction and recovery insights.

Positive
  • Launch of PainBlock Pro app enhances patient engagement and recovery tracking.
  • Allows healthcare providers to customize pain management based on real-time patient data.
  • User-friendly design facilitates easy access to educational resources for patients.
Negative
  • None.

ALPHARETTA, Ga., Dec. 2, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its PainBlock Pro data collection and patient engagement app. The app/text message-based platform allows healthcare providers to track patients' recovery in real time for up to 10 days post-surgery.

PainBlock Pro supports patient interaction with easy-to-use technology providing critical insight to recovery.

The user-friendly app tracks patient progress by collecting patient reported outcomes (PROs) through quick daily surveys before and after surgery, through the completion of the pain management therapy. Data from the surveys can help providers create personalized pain management plans based on a number of key factors, including the patient's level of pain, opioid consumption and overall satisfaction.

With one-click access, patients can also use the PainBlock Pro app to read FAQs, watch helpful videos and review educational resources related to their pain management.

"Gathering real-time patient feedback is an important first step in getting patients back to the things that matter," said Bill Haydon, Senior Vice President and General Manager of Avanos' Pain franchise. "The PainBlock Pro app allows healthcare providers to interact with their patients with easy-to-use technology that provides critical insight into the recovery process."

Healthcare professionals interested in learning more about the new app or requesting an onsite demonstration should visit https://avanospainmanagement.com/solutions/acute-pain/painblock-pro/.

About Avanos Medical:
Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients' quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries. For more information, visit www.avanos.com and follow Avanos Medical on Twitter (@AvanosMedical), LinkedIn and Facebook.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-launches-painblock-pro-app-301436389.html

SOURCE Avanos Medical, Inc.

FAQ

What is the PainBlock Pro app from Avanos Medical?

The PainBlock Pro app is a data collection and patient engagement platform that tracks recovery for up to 10 days post-surgery through daily surveys.

How does PainBlock Pro benefit healthcare providers?

It enables providers to gather real-time patient feedback and create personalized pain management plans based on key recovery metrics.

When was the PainBlock Pro app launched?

The PainBlock Pro app was launched on December 2, 2021.

What company launched the PainBlock Pro app?

The PainBlock Pro app was launched by Avanos Medical, Inc. (NYSE: AVNS).

How can patients learn more about PainBlock Pro?

Patients can access FAQs, videos, and educational resources directly through the PainBlock Pro app.

Avanos Medical, Inc.

NYSE:AVNS

AVNS Rankings

AVNS Latest News

AVNS Stock Data

868.13M
45.96M
2.95%
94%
1.64%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
ALPHARETTA